成都高新区：加速建设生物医药创新策源地

Core Insights - The 2025 China Biotechnology Innovation Conference was held in Chengdu High-tech Zone, showcasing the region's strong innovation vitality and leadership in the biopharmaceutical industry, ranking fourth in the 2024 China Biopharmaceutical Industry Park Annual Competitiveness Ranking [1] Group 1: Innovation Platforms - Chengdu High-tech Zone established the "Global New Drug Discovery Center" to foster original scientific achievements and leading talents, addressing challenges in drug development by integrating resources and promoting collaboration [2] - The region has developed multiple high-level innovation platforms, including the National Precision Medicine Industry Innovation Center and Tianfu Jincheng Laboratory, to enhance source innovation and result transformation capabilities [2] Group 2: Industry Growth - Chengdu High-tech Zone has attracted over 3,000 biopharmaceutical companies and established more than 160 functional platforms, with over 300 projects introduced and a total investment exceeding 120 billion yuan [3] Group 3: Policy and Financial Support - The region has implemented comprehensive policies to support the biopharmaceutical industry, focusing on strategic construction, innovation enhancement, and ecosystem development [4] - Chengdu High-tech Zone has created a six-in-one capital support system, forming 25 funds with a total scale of 35.2 billion yuan, and introduced unique financial products like "Bio Loan" to alleviate funding bottlenecks for innovative enterprises [5] Group 4: Future Outlook - Chengdu High-tech Zone aims to continue gathering global innovation resources and deepen the integration of industry, academia, and research, contributing significantly to the development of China's biopharmaceutical industry [6]